The Chung research group focuses on drug delivery and gene therapy, nanomedicine, and biomaterials to generate strategies to address the limitations of clinical solutions. A major focus of our work is regarding rare and genetic diseases. In particular, we are interested in biomimetic nanoparticles that can be designed to cross biological barriers and deliver molecular…